Home|Journals|Articles by Year|Audio Abstracts RSS - TOC
 

Original Research



Medication and symptom severity in schizophrenia patients in COVID-19 pandemic: A cross-sectional study

Asli Kazgan, Sevler Yildiz, Osman Kurt, Sevda Korkmaz.




Abstract

The present study aimed to determine the possible correlation between medical treatment [oral antipsychotics (OAP), long-acting injectable antipsychotics (LAI), oral + long-acting injectable antipsychotics (OAP + LAI)] and symptom severity, and the compliance of schizophrenia patients with the medication during the COVID-19 pandemic. The study was conducted with 100 schizophrenia patients who applied to the psychiatry outpatient clinic during the pandemic and met the study criteria. Sociodemographic data form, Positive and Negative Symptom Scale (PANSS), and Functional Recovery Scale in Schizophrenia (FRSS) were applied to each participant. The rate of patients who quit current treatment was 19%. A statistically significant difference was determined between the patients on OAP and those on LAI, and between those on OAP and those on OAP + LAI based on the overall scale scores (p

Key words: Schizophrenia, long-acting injectable antipsychotics, oral antipsychotics, COVID-19 pandemic






Full-text options


Share this Article



Online Article Submission
• ejmanager.com
• ojshosting.net




eJManager.com
Review(er)s Central
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.